Introduction
The protein disulphide-isomerases (PDIs) are a family of proteins initially defined by their ability to assist the formation of native disulphide bonds in secretory and cell-surface proteins during their biosynthesis, but now characterised structurally by the presence of one or more thioredoxin-fold (trx) domains, and by their location within the lumen of the endoplasmic reticulum. The human PDI family is large (> 17 members) and the structures and specific roles of the multiple family members have not yet been defined 1 ; the best-characterised is PDI itself, the archetype protein folding catalyst. PDI from a number of mammalian species has been studied for many years 2 and its properties as a catalyst of disulphideinterchange and associated protein folding are well-understood [3] [4] [5] [6] [7] .
When mammalian PDI was first cloned and sequenced, it was immediately recognised that it comprised multiple homologous domains 8 and subsequently the overall domain organization was defined as a-b-b'-x-a'-c, where a and a' are trx domains containing the active site dithiol sequence WCGHC, b and b'
have the trx conformation but lack the active-site motif, x is a linker region and c is a C-terminal acidic tail [9] [10] [11] [12] . This domain organization was finally confirmed by the x-ray structural analysis of full-length yeast Pdi1p [13] [14] . While the a and a' domains of human PDI can catalyse simple thiol:disulphide interchange reactions, the presence of the b' domain is essential for catalysis of protein disulphide isomerizations and for
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
3 non-covalent ligand binding [15] [16] ; the domains operate synergistically in linking catalytic and chaperone activities in protein folding 10 .
The b' domains of human PDI family members show greater sequence diversity than do the b, a and a' domains, and studies with hybrid and chimaeric species indicate that the specificities of PDIs for ligands and partner proteins are primarily defined by their b' domains; this has been confirmed in studies on the pancreas-specific isoform PDIp 17 , on the PDI homologue ERp57, which interacts specifically with the lectins calnexin and calreticulin [18] [19] [20] [21] , and on the newly-described protein ERp27 22 which comprises only b and b'-like domains. These results make it of particular interest to study --in molecular detail --the b' domains of PDIs and their interactions with ligands. Frustratingly, the b' domain of human PDI is the only domain for which the structure has not been solved and for several members of the family (e.g. PDIp, ERp27), the b'
domains do not give good yields of well-folded soluble protein when expressed as recombinant constructs in
E.coli.
We previously reported the expression and characterization of the b' and b'x domain fragments of human PDI, including defining the substrate binding site by modeling and mutagenesis studies 12 . In this paper we report further characterization of the recombinant b'x fragment and show that it exists in two distinct conformations which differ in tertiary structure, specifically in the environment of the unique Trp residue in the x region. From a screen of 75 mutants we identify mutants of b'x which exclusively adopt one or other of these alternative conformations. In addition, we report the crystal structure of one of these mutants, I272A; this reveals a hydrophobic pocket in the b' domain capped by the x region. All of the mutations we previously reported to inhibit substrate binding 12 shift the equilibrium in solution towards the capped conformer. Hence these mutations do not define the substrate binding site per se, but rather act indirectly to inhibit substrate binding by decreasing the accessibility of the substrate binding site. We present evidence that the two conformers are also significant in full-length PDI and suggest that these alternative conformations may explain some of the difficulties in characterizing the molecular properties of PDI and its sub-fragments and in understanding the ability of PDI to interact with folding substrates.
Results
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Preparations of recombinant human PDI b'x contain at least two conformers
The domain boundaries of human PDI were defined in previous work [11] [12] ; the constructs studied here correspond to the complete b' domain (P218-G332) and subsequent x region (K333-P351) with a short Nterminal tag (MHHHHHHMKHNQL-). The b' domain of human PDI contains no Trp residues, but there is a single Trp residue located in the x region (W347). Despite only having a single tryptophan, preparations of recombinant b'x gave a fluorescence emission spectrum with two maxima at approximately 334 nm and 355 nm (Fig 1a and ref 12 ). Furthermore, in HSQC spectra of 15 N-labelled human PDI b'x (Fig 1b) there were two peaks for the characteristic Trp indole sidechain resonance (shown boxed). There was, however, no indication of heterogeneity by mass spectrometry (data not shown). We have previously shown that b'x preparations give a CD spectrum consistent with substantial α-helix and β-sheet content and a single denaturation transition curve with a midpoint of 2.32 M guanidine hydrochloride 12 infer that the b'x fragment can exist in at least two alternative structured conformations. In one conformation (which we term the 'capped' form), the Trp residue in the x linker is buried in a hydrophobic environment, whereas in the other conformation (which we term the 'uncapped' form) the Trp residue is exposed to solvent. Analysis by fluorescence spectroscopy (Fig 1c,d) and CD (not shown) indicated that the ratio between these conformers could be altered by the applied salt concentration and that in dilute conditions at room temperature this salt-induced change in structure was reversible.
Screening mutations that trap a single conformation of PDI b'x
To generate homogenous preparations of the 'capped' and 'uncapped' conformers, we decided to screen for mutants in the b'x construct which might alter the conformer distribution, stabilising one relative to the other and allowing a single species to be characterised in detail. Since the fluorescence spectrum gave an easily-diagnosable read-out of the proportions of the 'capped' and 'uncapped' forms, this was chosen for the screen. In total 75 mutants of b'x were screened, a significant proportion of which were generated previously 12 . These mutants were purified on a micro-scale and their fluorescence spectra recorded in the elution buffer immediately after purification. Many of the mutants --like the wild type protein --showed a A C C E P T E D M A N U S C R I P T
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5 mixed fluorescence spectrum with peaks at approximately 334 nm and 355 nm. However, some mutants showed a significant red-shift in fluorescence spectrum towards a single 355 nm peak (e.g. L343A, Fig 2a) while others showed a significant blue-shift towards a single 334nm peak (e.g. I272A, Fig 2b) . Since the concentrations of the proteins obtained from the micro-scale purification varied by about three-fold, the parameter chosen to cross-compare spectra was the ratio of the average fluorescence at 331-337 nm to the average fluorescence at 352-358 nm. This ratio in elution buffer was 1.03 for the wild type protein and varied from 0.78 (extremely red-shifted) to 1.29 (extremely blue-shifted) for the mutant proteins (Fig 2c) .
Many of the mutations which resulted in a significant shift in the fluorescence ratio were either located in the vicinity of the substrate binding site as defined previously 12 or were located in x. No significant differences were observed in the fluorescence ratios of the wild type, I272A or L343A mutant b'x constructs when excited at 280 or 295nm.
NMR studies of PDI b'x constructs
Two red-shifted and three blue-shifted mutants in b'x were chosen for purification to homogeneity on the milligram scale. Fluorescence analysis of these mutant proteins confirmed the results obtained from the micro-scale purification (data not shown). The CD spectra were characteristic of globular proteins with defined secondary structure, although the spectra were clearly different in detail from each other and from the wild-type protein (data not shown). The mutant proteins were generated in 15 N-labelled form. HSQC spectra of the five mutants showed significant differences between them in resolved resonances, average line shape and dispersion. The HSQC spectra of the blue-shifted mutants, I272A (Fig 3a) , D346A/D348A and I272A/D346A/D348A (data not shown), gave well resolved spectra consistent with a folded protein of the expected molecular size. In contrast, the HSQC spectra of the red-shifted mutants, L343A (Fig 3b) and K349A (not shown), revealed both purified proteins as having poorly defined broad resonances characteristic of conformational exchange over the NMR experimental time scale due to significant structural differences and/or the presence of multimeric interactions. If we assume that the proportion of 'uncapped' and 'capped'
forms can be judged from the intensity of the two resonances from the Trp indole HN, then the two redshifted mutants appear to be entirely in the 'uncapped' form, whereas all blue-shifted mutants had substantially less of the 'uncapped' form than the unfractionated wild-type sample (Fig 1b) . The amount of
'uncapped' form was estimated for each blue-shifted mutant and found to decrease in the order D346A/D348A > I272A > the triple mutant I272A/D346A/D348A, with the triple mutant containing essentially none of this conformer. These results suggest that the blue-shift mutations act to stabilise the 'capped' form relative to the 'uncapped' form and that the effect of the blue-shift mutations is additive.
Crystallography of mutant PDI b'x
Despite numerous attempts, we have been unable to obtain crystals from wild-type PDI b' or b'x, a situation we tentatively assigned to the mixed conformers present. To test this hypothesis, we tried to crystallize the I272A and D346A/D348A mutants of human PDI b'x which had appeared by NMR to be predominantly in a single conformation. Both mutants gave crystals, but despite extensive optimization we were unable to improve the crystallization of the D346A/D348A mutant to obtain crystals which diffracted well. In contrast, we obtained crystals of the I272A mutant which diffracted well using 3 different conditions.
Excluding the high B-factor loop which contains E304, E305 and E306, the crystals obtained under the three conditions gave structures whose backbone traces were effectively super-imposable. We chose to refine the structure of the pH 8.5 crystal, since the diffraction pattern was slightly better than that obtained at pH 7.5
and since it is closer to physiological pH than the crystal obtained at pH 9.5. This structure has been refined at 2.2Å resolution (Table 1 ). There is one monomer per asymmetric unit. Seventeen residues were not observed in the electron density map, these being the three C-terminal residues (K349-P351) and fourteen Nterminal residues comprising the His-tag and the first residue of the PDI sequence (P218). Therefore the ordered part of the b'x construct in the crystal structure extends from L219 to D348. The final model contains 2 cis-peptide bonds (C295-P296 and E304-E305).
The crystal structure of the b' domain of the I272A b'x construct (Fig 4a,b ) unsurprisingly exhibits a PDI-type trx fold (ßαßαßαßßα). Part of the x region (residues P336-L338) forms an additional β-strand to the mixed β-sheet core of the trx fold and the rest of x loops round to remain juxtaposed to b' with residues E345-W347 forming a short C-terminal helix.
The b' domain of PDI binds peptides and non-native proteins via predominantly hydrophobic interactions [16] [17] and hence a hydrophobic surface or solvent exposed hydrophobic pocket might be expected
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7 on b'. Surface charge density maps (Fig 4c) of b' reveal a hydrophobic pocket on one face of the domain which is capped by the x region (Fig 4d) . Specifically, the side-chain of M339 (the first residue after the β- 
Evidence for alternative conformations of the x region in full-length PDI
Previously we showed that limited proteolysis of full length bovine PDI results in the formation of fragments in which the x region was associated either with the b' domain or with the a' domain, but that cleavage at an internal site in the x region was never observed 23 . This implies that the x region is structured and that this structure can be associated with either of the adjacent domains. While such an observation is consistent with the crystal structure of the capped conformer of b'x, care must be taken in interpreting proteolytic data in that conformational exchange of fragments can be different from that in the intact
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8 molecule and in the case of PDI it is likely that proteolytic fragments will be bound by the substrate binding site and will therefore perturb any conformational exchange in the full length protein.
Full length human PDI contains five tryptophan residues, two in the a domain (W35, W111), and two in a' (W379, W390), in addition to the one in x (W347). Hence its fluorescence emission is complex and it was not possible to use fluorescence to test whether the two conformational states (capped and uncapped) occur in the wild-type protein. The fluorescence of W35 in the WCGHC active site motif is very heavily quenched in both the dithiol and disulphide states 24 and similarly W379 in the WCGHC active site motif of the a' domain would be expected to be heavily quenched. Hence in a W111F / W390F mutant PDI, the fluorescence of W347 would be expected to predominate. Micro-scale purification of this mutant revealed a tryptophan fluorescence spectrum that showed two distinct maxima (data not shown) though the spectrum overall was red-shifted compared to wild-type b'x (fluorescence ratio = 0.916 ±0.014, n=14). Informed by the b'x screen, two 'blue-shift' mutations (I272A and D346A/D348A) were then made in the W111F / W390F mutant background and both resulted in shifts towards the 'capped' form, similar to that observed in the isolated b'x construct (fluorescence ratios = 1.068 ±0.015 (n=7) and 1.021 ±0.009 (n=2) respectively).
Similarly the 'red-shift' mutation L343A resulted in a shift towards the 'uncapped' form (fluorescence ratio = 0.865 ±0.005, n=3), though with a smaller shift than that observed for wild-type vs L343A b'x (see Fig 2) .
To confirm that the observed two-state nature of the fluorescence spectra was due to alternative environments of W347 in the x region, the quadruple-mutant W35F / W111F / W379F / W390F of PDI was made along with one 'red-shift' (L343A) and one 'blue-shift' (I272A) mutant in this background. As for the mutants in the W111F/W390F background, the L343A and I272A mutants in the 'quadruple W-mutant' background resulted in a 'red-shift' and 'blue-shift' respectively. However, proteolysis revealed that the additional mutations in W35 and W379 clearly destabilized the protein relative to wild type (data not shown).
Overall the fluorescence data imply that the two conformers seen in the isolated b'x domain, corresponding to alternative environments for the x region, also occur in full length PDI and that the relative proportions of each conformer are affected in the same way by the same mutations. However, all of these fluorescence data were obtained from mutated forms of PDI.
To examine whether the conformational exchange occurs in wild type full length PDI, NMR based analysis was undertaken. Full length human PDI is 55kDa, too large for a full structural analysis. Instead we (Fig. 5 ). This indicates that W347 in full length wild-type PDI also experiences conformational exchange between 'capped' and 'uncapped' forms.
Previously there has been a debate on whether substrate binding by PDI is redox modulated [25] [26] . No significant redox dependent changes were seen in the fluorescence spectra of wild type, I272A or L343A mutant b'x constructs or in the full length PDI W111F/W390F construct. Furthermore there was no significant redox-dependent difference in the appearance of the W347 resonance in the 15 N-1 H HSQC spectrum of full length wild type PDI. These observations indicate that there is no redox dependence for the conformational exchange between the 'capped' and 'uncapped' conformers and are consistent with the report that PDI is not a redox-dependent molecular chaperone 26 .
Discussion
A high resolution structure of the b'x region of human PDI
The biological significance of mammalian PDI in the folding of disulphide-bonded secretory proteins has been clear for many years 2 and throughout that time pure protein has been abundantly available, either from mammalian tissues or recombinant sources [27] [28] . No high-resolution structure of a full-length PDI from a multicellular organism has been achieved to date, despite the fact that many groups have attempted to In the current paper we have analysed recombinant human b'x in detail --using a range of techniques for structural study in solution --and identified the existence of at least two conformational states which clearly differ in the structural relationship between the x region (specifically W347) and the b' domain.
In order to overcome the complexities introduced by the existence of these states, we sought to generate mutants which might preferentially stabilize one state and eliminate the conformational heterogeneity. Using fluorescence screening we were able to identify mutants which preferentially adopted one or other conformation and we have crystallized and determined the structure of the I272A mutant of b'x, which we inferred to be entirely in the 'capped' conformation. In accordance with our inference from solution studies on this mutant and on wild-type b'x, the x region is intimately associated with the b' domain in the crystal structure of b'x I272A, and the indole side-chain of W347 is buried in a hydrophobic pocket.
Comparison with b' and x conformations in other PDI family structures
In Fig 6a we domains of other PDI-family members including the bb' fragment of human ERp57 (2h81), the b' domain of
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11 yeast Pdi1p (2be5), the bb' fragment from human PDI (2k18; structure released whilst this manuscript was in review) and the b' domain from the thermophilic fungus Humicola insolens (2djk) along with other thioredoxin fold containing proteins.
However there is a major difference between the human and yeast PDI structures in the orientation of the x region, which in the Pdi1p structure does not cap the hydrophobic surface of b' as is observed for capped human PDI b'x (Fig 6b) . Were human PDI b'x to adopt such an arrangement as found in yeast Pdi1p, W347 in the x region would be solvent exposed and probably highly mobile, consistent with the fluorescence data for the 'uncapped' conformer of the wild-type human b'x protein. We infer that the structure of the 'uncapped' conformer of wild-type human b'x has some similarities to that observed in the crystal structure of yeast Pdi1p and that the identified 'red-shifting' mutations act by stabilising this structure in isolated human b'x.
In analyzing their structure of yeast Pdi1p, Tian et al. 13 drew attention to a 'highly hydrophobic pocket' on the surface of the b' domain (Fig 6b) which -together with hydrophobic patches at homologous positions on the surfaces of the a, b and a' domains -forms a continuous hydrophobic surface. We had previously proposed that the b' domain provided the principal binding site on PDI for peptides and unfolded proteins, based on studies on human PDI domains and domain combinations 12, 16 . Functional studies on yeast Pdi1p mutants by Tian et al. 13 confirm that this conclusion is also valid for the yeast enzyme. In Fig 6a, the residues which contribute side-chains to the 'highly hydrophobic pocket' identified by Tian et al. 13 are highlighted and the corresponding residues in the structurally-aligned human sequence are also highlighted.
Also in Fig 6a, we identify the residues of the b' domain of human b'x which form hydrophobic contacts with the sidechains of L343 and W347 of the x linker. It is clear that the x linker is retained in close contact with the b' domain by binding in the centre of a wider hydrophobic surface which corresponds to the hydrophobic pocket identified by Tian et al. 13 in the yeast Pdi1p structure and which has been identified as the putative ligand binding site (Fig 6b) . Hence the interaction of x with b' probably mimics substrate binding.
Previously we identified the substrate binding site in PDI by a combination of modelling and mutagenesis studies 12 . The binding site identified by those studies was not based on a high resolution structure and does not match that identified here or by Tian et al. 13 . However, all of the mutations previously identified to inhibit substrate binding (including I272A) are blue-shift mutants (compare data presented in reference 12 with that in fig 2c) . Hence these mutations are not in residues directly involved in interaction with substrates but rather they act indirectly by stabilizing the conformer in which the hydrophobic pocket is 'capped' by x relative to the 'uncapped' conformer. Hence our previous results showing that these mutations in b'x or full length PDI result in a loss of ability to bind substrates suggest that, once capped by x, the substrate binding site is unavailable to bind substrates.
Functional significance of novel structural interaction between b' domain and x linker
This work has i) demonstrated that there is an intrinsic conformational heterogeneity in isolated domain of human PDI we report here (Fig. 7) . A superposition of the backbone atoms (N, Cα, C) for 19 residues in structurally analogous positions across all 5 β-strands gave a RMSD of 0.57Å. Likewise the nature of the interaction of the carboxy terminal extension with the hydrophobic pocket in ERp44 is similar to that of the x region capping the binding site in the b' domain of PDI, with L361 in ERp44 playing a role similar to that of W347 in PDI. Deletion of the C-terminal tail in ERp44 increased the activity of ERp44 and its ability to act as a molecular chaperone 31 , both consistent with a regulatory role for the tail. The emergence of two such similar structures suggests that this may be a common regulatory mechanism within the PDI family.
Materials and Methods
Mutagenesis, expression and purification
The plasmid containing the gene encoding the human PDI b'x domain fragment is a derivative of pET23b (Novagen). The resulting protein is expressed with an N-terminal His tag MHHHHHHM and encodes residues K213 to P351 of mature PDI. Mutagenesis, transformation, expression and purification were done as described previously
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Purification on a micro-scale from 5-10 ml of bacterial culture for fluorescence screening of mutants was done using Ni-NTA spin columns (Qiagen) according to the protocol recommended by the manufacturer. 
Spectroscopy
NMR spectroscopy
Cells were grown in minimal medium to allow isotopic labeling using 1 g/l 15 N ammonium sulphate as sole nitrogen source and labelled protein was expressed and purified as described previously 12 . Samples for NMR analysis were concentrated to between 0.36 mM and 1 mM in 20 mM phosphate buffer (pH 6.5) containing 150 mM NaCl by centrifugation on Vivaspin columns with a 5 kD cut-off and then D 2 O added to a final concentration of 10% (v/v). 15 N/ 1 H HSQC spectra were collected at 25°C as described in Alanen et al. 22 .
Crystallization
To prepare selenium-labelled protein a fresh colony of E.coli B834 ( the same method at pH 7.5, 8.5 and 9.5. Crystals were harvested from drops, put into paraffin oil for a few seconds and then frozen in liquid nitrogen. X-ray data were collected at cryogenic temperature (100 K).
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Data collection, structure determination and refinement
Multiwavelength anomalous dispersion (MAD) data were collected for the Se-Met crystal on CCD detector at beamline BW7A (DESY, Hamburg, Germany). The x-ray data from native crystals at pH 7.5, 8.5
and 9.5 were collected at X12 (DESY, Hamburg, Germany). Images were processed using the XDS program package [33] [34] . Using the Auto-RickShaw protocol [35] [36] , the MAD-dataset resulted in the initial model that was completed with COOT 37 . Subsequently the structure of the native datasets were refined using REFMAC5 38 with the translation libration screw (TLS) description of the anisotropic rigid body motion 39 . The data collection statistics and refinement statistics of the pH 8.5 structure are given in Table 1 . The model includes 45 waters and one sulphate ion.
Protein Data Bank accession code
The and W347 in the human structure are shown in green. The two views are in the same orientation (achieved by superposition of the core β-sheet) corresponding to that in Fig 4b and c. This figure was generated using MOLMOL 40 .
Figure 7 Structural comparison of human PDI b'x and ERp44
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The two structures are shown in the same orientation as determined by superposition of their β-strands. The x region is shown in green for human PDI and magenta for ERp44. The sidechains of the residues important for hydrophobic interaction of x with b' (L343 and W347 in PDI, and F358 and L361in ERp44) are also
shown. The sidechain of L361 in ERp44 is in an analogous position to W347 in PDI. 
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